Role of antiarrhythmic drugs in reducing the number of defibrillation shocks;Place des anti-arythmiques dans la réduction du nombre de chocs des défibrillateurs

Archives des Maladies du Coeur et des Vaisseaux

Volumn 98, Issue 2, 2005, Pages 140-144

  Deharo, J C ^b   Mouliom, F ^b   Salamand, A ^b   Djiane, P ^a  

^a TIMONE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; LIDOCAINE; PLACEBO; PROPAFENONE; QUINIDINE; SOTALOL;

DEFIBRILLATION; FOLLOW UP; HEART ARREST; HEART ARRHYTHMIA; HUMAN; PROBABILITY; REVIEW; CLINICAL TRIAL; DEFIBRILLATOR; MULTIMODALITY CANCER THERAPY; TACHYCARDIA;

ANTI-ARRHYTHMIA AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; HUMANS; TACHYCARDIA;

EID: 18344396076     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Moss AJ, Hall WJ. Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmias. Multicenter Automatic Defibrillator Implantation Trial investiqafors. N Engl J Med 1996 ; 335 : 1933-40.
2. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. Multicenter Automatic Defibrillator Implantation Trial II investigators. N Engl J Med 2002 ; 346 : 877-83.
3. Buxton AE, Lee KI, Fischer JD et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999 ; 341 : 1882-90.
4. The antiarrhythmic versus implantable defibrillator (AVID) investigators. A comparison or antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from near-fatal sustained ventricular arrhythmia. N Engl J Med 1997 ; 337 : 1576-83.
5. Kuck KH, Cappato R, Sienels J et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hambourg (CASH). Circulation 2000 ; 102 : 748-54.
6. Connolly SJ, Gent M, Roberts RS et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000 ; 101 : 1297-302.
7. Steinberg JS, Martins J, Sadanandan S et al. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmic Versus Implantable Defibrillator (AVID) study. Am Heart J 2001 ; 142 : 520-9.
8. Greene HL. Interactions between pharmacologic and nonpharmacologic antiarrhythmic therapy. Am J Cardiol 1996 ; 78 (suppl 4A) : 61-6.
9. Dorian P, Mangat I. Role of amiodarone in the era of implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2003 ; 14 : S78-S81.
10. Schron EB, Exner DV, Yao Q et al. Quality of life in the Antiarrhythmic Versus implantable Defibrillators Trial-Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002 ; 105 : 589-94.
11. The CASCADE investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study). Am J Cardiol 1993 ; 72 : 280-7.
12. Pacifico A, Hohnloser S, Williams JH et al. Prevention of implatable-defibrillator shocks by treatment with sotalol. N Engl J Med 1999 ; 340 : 1855-62.
13. Manz M, Jung W, Lüderitz B. Interaction between drugs and devices: experimental and clinical studies. Am Heart J 1994 ; 127 : 978-84.
14. Page RL. Effects of antiarrhythmic medication on implantable cardioverter-defibrillator function. Am J Cardiol 2000 ; 85 : 1481-5.
15. Dorian P, Fain ES, Davy JM, Winlae RA. Effect of quinidine and bretylium on defibrillation requirements. Am Heart J 196 ; 112 : 19-25.
16. Stevens SK, Haffaje CI, Naccarelli GV et al. Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 1996 ; 28 : 418-22.
17. Dorian P, Newman D. Effect of sotalol on ventricular fibrillation and defibrillation in humans. Am J Cardiol 1993 ; 72 : 72A-79A.